Moore Capital Management »

Novo Nordisk A/S shares owned by Moore Capital Management

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.9M 18k 103.45
2023-09-30 $9.4M 103k 90.94
2023-06-30 $8.1M 50k 161.83

More positions owned by Moore Capital Management

Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Meta Platforms Cl A (META)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Spdr Ser Tr S&p Biotech (XBI)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Ally Financial (ALLY)
Allstate Corporation (ALL)
Spdr Ser Tr S&p Regl Bkg (KRE)
Vaneck Etf Trust Gold Miners Etf (GDX)
salesforce (CRM)
Progressive Corporation (PGR)
Vertiv Holdings Com Cl A (VRT)
Select Sector Spdr Tr Indl Call Option (XLI)

View all positions for Moore Capital Management

Top funds holding Novo Nordisk A/S

Jennison Associates
Fisher Investments
Bank of America Corporation
Fayez Sarofim & Co
Folketrygdfondet
Polen Capital Management
T. Rowe Price Associates
Everett Harris & Co
State Farm Mutual Automobile Insurance Company
Goldman Sachs Group
Jpmorgan Chase & Co
WCM Investment Management
Wells Fargo & Company
Sustainable Growth Advisers
Royal Bank of Canada

View all funds holding Novo Nordisk A/S